The estimated Net Worth of James G Hall is at least $1.37 Million dollars as of 23 July 2021. Mr. Hall owns over 9,199 units of Lifecore Biomedical Inc stock worth over $409,276 and over the last 7 years he sold LNDC stock worth over $0. In addition, he makes $960,196 as Vice President and President of Lifecore at Lifecore Biomedical Inc.
James has made over 6 trades of the Lifecore Biomedical Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 9,199 units of LNDC stock worth $108,732 on 23 July 2021.
The largest trade he's ever made was exercising 25,000 units of Lifecore Biomedical Inc stock on 1 June 2020 worth over $271,000. On average, James trades about 4,080 units every 77 days since 2017. As of 23 July 2021 he still owns at least 46,721 units of Lifecore Biomedical Inc stock.
You can see the complete history of Mr. Hall stock trades at the bottom of the page.
James G. Hall serves as Vice President, President of Lifecore of the Company. Mr. Hall has been President of Lifecore and a Vice President of the Company since June 2017. At Lifecore, Mr. Hall served as Vice President and General Manager from July 2013 to June 2017, Vice President of Operations from 2006 to 2013; Director of Manufacturing Operations and Engineering from 2001 to 2006; and the Manager of Engineering and Operations from 1999 to 2001. From 1995 until joining Lifecore in 1999, Mr. Hall was Manager of Pre-Clinical and Clinical supply for Protein Design Labs, a biotechnology company focusing on humanizing monoclonal antibodies. Prior to joining Protein Design Labs in 1995, Mr. Hall held various engineering positions within Lifecore beginning in 1989. Mr. Hall has over 29 years of pharmaceutical and combination product manufacturing and development experience.
As the Vice President and President of Lifecore of Lifecore Biomedical Inc, the total compensation of James Hall at Lifecore Biomedical Inc is $960,196. There are 2 executives at Lifecore Biomedical Inc getting paid more, with Dr. Albert D. Bolles Ph.D. having the highest compensation of $989,459.
James Hall is 57, he's been the Vice President and President of Lifecore of Lifecore Biomedical Inc since 2017. There are 14 older and 4 younger executives at Lifecore Biomedical Inc. The oldest executive at Lifecore Biomedical Inc is Charles Macaluso, 76, who is the Independent Director.
James's mailing address filed with the SEC is 5201 Great America Pkwy #232, Santa Clara, CA 95054, USA.
Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp..., and Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Lifecore Biomedical Inc executives and other stock owners filed with the SEC include: